Pancreatic cancer
Results
Phase 1
This trial looked at whether stereotactic body radiotherapy (SBRT) could help shrink pancreatic cancer before surgery to remove it. It was for people with cancer that doctors hoped they could remove with surgery, but the operation was likely to be difficult.
The trial was supported by Cancer Research UK. It was open for people to join between 2015 and 2018. The team published the results in 2021.
Recruitment start: 17 April 2015
Recruitment end: 22 March 2018
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Maria A. Hawkins
Cancer Research UK
Experimental Cancer Medicine Centre (ECMC)
Cancer Research UK Oxford Centre
CRUK/MRC Oxford Institute for Radiation Oncology
Oncology Clinical Trials Office (OCTO)
Oxford Clinical Trials Research Unit (OCTRU)
University of Oxford
National Institute for Health Research (NIHR)
This is Cancer Research UK trial number CRUK/14/028.
Last reviewed: 01 Mar 2022
CRUK internal database number: 12660